The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Amyotrophic Lateral Sclerosis Drugs Market Research Report 2025

Global Amyotrophic Lateral Sclerosis Drugs Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1713819

No of Pages : 89

Ask Your Query

Synopsis
Market Analysis and Insights: Global Amyotrophic Lateral Sclerosis Drugs Market

Amyotrophic lateral sclerosis is a neurodegenerative disease. ALS affects the nerve cells in the brain and spinal cord that control the voluntary muscles. It is also known as the Lou Gehrig’s disease. Amyotrophic lateral sclerosis can be caused due to various factors such as genetics or environmental factors such as exposure to toxic or infectious agents, viruses, physical trauma, diet, and behavioral and occupational factors.

The global Amyotrophic Lateral Sclerosis Drugs market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Amyotrophic Lateral Sclerosis Drugs includes Riluzole, Edaravone (Radicava), CoQ10, Baclofen, Butylphthalide and Others. These drugs prolong amyotrophic lateral sclerosis (ALS) survival and slow the disease's progression in some people. Currently, only riluzole and edaravone have been approved for the treatment of ALS.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Amyotrophic Lateral Sclerosis Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Amyotrophic Lateral Sclerosis Drugs market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Amyotrophic Lateral Sclerosis Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Amyotrophic Lateral Sclerosis Drugs market.

Global Amyotrophic Lateral Sclerosis Drugs Scope and Market Size
Amyotrophic Lateral Sclerosis Drugs market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Amyotrophic Lateral Sclerosis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Riluzole
  • Edaravone (Radicava)
  • CoQ10
  • Butylphthalide
  • Others

Segment by Application

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

By Company

  • Sanofi
  • Mitsubishi Tanabe Pharma
  • Mylan
  • Apotex
  • Glemark Generics
  • Sun Pharma
  • Covis Pharma
  • Lunan Pharma
  • Cspc Pharmaceutical
  • Ascend Laboratories
  • Eisai
Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Amyotrophic Lateral Sclerosis Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Riluzole
1.2.3 Edaravone (Radicava)
1.2.4 CoQ10
1.2.5 Butylphthalide
1.2.6 Others
1.3 Market by Application
1.3.1 Global Amyotrophic Lateral Sclerosis Drugs Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Amyotrophic Lateral Sclerosis Drugs Market Perspective (2017-2028)
2.2 Amyotrophic Lateral Sclerosis Drugs Growth Trends by Region
2.2.1 Amyotrophic Lateral Sclerosis Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Amyotrophic Lateral Sclerosis Drugs Historic Market Size by Region (2017-2022)
2.2.3 Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Region (2023-2028)
2.3 Amyotrophic Lateral Sclerosis Drugs Market Dynamics
2.3.1 Amyotrophic Lateral Sclerosis Drugs Industry Trends
2.3.2 Amyotrophic Lateral Sclerosis Drugs Market Drivers
2.3.3 Amyotrophic Lateral Sclerosis Drugs Market Challenges
2.3.4 Amyotrophic Lateral Sclerosis Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Amyotrophic Lateral Sclerosis Drugs Players by Revenue
3.1.1 Global Top Amyotrophic Lateral Sclerosis Drugs Players by Revenue (2017-2022)
3.1.2 Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Amyotrophic Lateral Sclerosis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Amyotrophic Lateral Sclerosis Drugs Revenue
3.4 Global Amyotrophic Lateral Sclerosis Drugs Market Concentration Ratio
3.4.1 Global Amyotrophic Lateral Sclerosis Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Amyotrophic Lateral Sclerosis Drugs Revenue in 2021
3.5 Amyotrophic Lateral Sclerosis Drugs Key Players Head office and Area Served
3.6 Key Players Amyotrophic Lateral Sclerosis Drugs Product Solution and Service
3.7 Date of Enter into Amyotrophic Lateral Sclerosis Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Amyotrophic Lateral Sclerosis Drugs Breakdown Data by Type
4.1 Global Amyotrophic Lateral Sclerosis Drugs Historic Market Size by Type (2017-2022)
4.2 Global Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Type (2023-2028)
5 Amyotrophic Lateral Sclerosis Drugs Breakdown Data by Application
5.1 Global Amyotrophic Lateral Sclerosis Drugs Historic Market Size by Application (2017-2022)
5.2 Global Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Amyotrophic Lateral Sclerosis Drugs Market Size (2017-2028)
6.2 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2017-2022)
6.3 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Amyotrophic Lateral Sclerosis Drugs Market Size (2017-2028)
7.2 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2017-2022)
7.3 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size (2017-2028)
8.2 Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2017-2022)
8.3 Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Amyotrophic Lateral Sclerosis Drugs Market Size (2017-2028)
9.2 Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2017-2022)
9.3 Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size (2017-2028)
10.2 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2017-2022)
10.3 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Amyotrophic Lateral Sclerosis Drugs Introduction
11.1.4 Sanofi Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2017-2022)
11.1.5 Sanofi Recent Development
11.2 Mitsubishi Tanabe Pharma
11.2.1 Mitsubishi Tanabe Pharma Company Detail
11.2.2 Mitsubishi Tanabe Pharma Business Overview
11.2.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Introduction
11.2.4 Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2017-2022)
11.2.5 Mitsubishi Tanabe Pharma Recent Development
11.3 Mylan
11.3.1 Mylan Company Detail
11.3.2 Mylan Business Overview
11.3.3 Mylan Amyotrophic Lateral Sclerosis Drugs Introduction
11.3.4 Mylan Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2017-2022)
11.3.5 Mylan Recent Development
11.4 Apotex
11.4.1 Apotex Company Detail
11.4.2 Apotex Business Overview
11.4.3 Apotex Amyotrophic Lateral Sclerosis Drugs Introduction
11.4.4 Apotex Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2017-2022)
11.4.5 Apotex Recent Development
11.5 Glemark Generics
11.5.1 Glemark Generics Company Detail
11.5.2 Glemark Generics Business Overview
11.5.3 Glemark Generics Amyotrophic Lateral Sclerosis Drugs Introduction
11.5.4 Glemark Generics Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2017-2022)
11.5.5 Glemark Generics Recent Development
11.6 Sun Pharma
11.6.1 Sun Pharma Company Detail
11.6.2 Sun Pharma Business Overview
11.6.3 Sun Pharma Amyotrophic Lateral Sclerosis Drugs Introduction
11.6.4 Sun Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2017-2022)
11.6.5 Sun Pharma Recent Development
11.7 Covis Pharma
11.7.1 Covis Pharma Company Detail
11.7.2 Covis Pharma Business Overview
11.7.3 Covis Pharma Amyotrophic Lateral Sclerosis Drugs Introduction
11.7.4 Covis Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2017-2022)
11.7.5 Covis Pharma Recent Development
11.8 Lunan Pharma
11.8.1 Lunan Pharma Company Detail
11.8.2 Lunan Pharma Business Overview
11.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis Drugs Introduction
11.8.4 Lunan Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2017-2022)
11.8.5 Lunan Pharma Recent Development
11.9 CSPC Pharmaceutical
11.9.1 CSPC Pharmaceutical Company Detail
11.9.2 CSPC Pharmaceutical Business Overview
11.9.3 CSPC Pharmaceutical Amyotrophic Lateral Sclerosis Drugs Introduction
11.9.4 CSPC Pharmaceutical Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2017-2022)
11.9.5 CSPC Pharmaceutical Recent Development
11.10 Ascend Laboratories
11.10.1 Ascend Laboratories Company Detail
11.10.2 Ascend Laboratories Business Overview
11.10.3 Ascend Laboratories Amyotrophic Lateral Sclerosis Drugs Introduction
11.10.4 Ascend Laboratories Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2017-2022)
11.10.5 Ascend Laboratories Recent Development
11.11 EISAI
11.11.1 EISAI Company Detail
11.11.2 EISAI Business Overview
11.11.3 EISAI Amyotrophic Lateral Sclerosis Drugs Introduction
11.11.4 EISAI Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2017-2022)
11.11.5 EISAI Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Amyotrophic Lateral Sclerosis Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Riluzole
Table 3. Key Players of Edaravone (Radicava)
Table 4. Key Players of CoQ10
Table 5. Key Players of Butylphthalide
Table 6. Key Players of Others
Table 7. Global Amyotrophic Lateral Sclerosis Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Amyotrophic Lateral Sclerosis Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Amyotrophic Lateral Sclerosis Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Region (2017-2022)
Table 11. Global Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Region (2023-2028)
Table 13. Amyotrophic Lateral Sclerosis Drugs Market Trends
Table 14. Amyotrophic Lateral Sclerosis Drugs Market Drivers
Table 15. Amyotrophic Lateral Sclerosis Drugs Market Challenges
Table 16. Amyotrophic Lateral Sclerosis Drugs Market Restraints
Table 17. Global Amyotrophic Lateral Sclerosis Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Players (2017-2022)
Table 19. Global Top Amyotrophic Lateral Sclerosis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amyotrophic Lateral Sclerosis Drugs as of 2021)
Table 20. Ranking of Global Top Amyotrophic Lateral Sclerosis Drugs Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Amyotrophic Lateral Sclerosis Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Amyotrophic Lateral Sclerosis Drugs Product Solution and Service
Table 24. Date of Enter into Amyotrophic Lateral Sclerosis Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Type (2017-2022)
Table 28. Global Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Type (2023-2028)
Table 30. Global Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Application (2017-2022)
Table 32. Global Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Application (2023-2028)
Table 34. North America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 35. North America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 36. Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 37. Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 38. Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 39. Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 40. Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 41. Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 42. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 43. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 44. Sanofi Company Detail
Table 45. Sanofi Business Overview
Table 46. Sanofi Amyotrophic Lateral Sclerosis Drugs Product
Table 47. Sanofi Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2017-2022) & (US$ Million)
Table 48. Sanofi Recent Development
Table 49. Mitsubishi Tanabe Pharma Company Detail
Table 50. Mitsubishi Tanabe Pharma Business Overview
Table 51. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Product
Table 52. Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2017-2022) & (US$ Million)
Table 53. Mitsubishi Tanabe Pharma Recent Development
Table 54. Mylan Company Detail
Table 55. Mylan Business Overview
Table 56. Mylan Amyotrophic Lateral Sclerosis Drugs Product
Table 57. Mylan Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2017-2022) & (US$ Million)
Table 58. Mylan Recent Development
Table 59. Apotex Company Detail
Table 60. Apotex Business Overview
Table 61. Apotex Amyotrophic Lateral Sclerosis Drugs Product
Table 62. Apotex Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2017-2022) & (US$ Million)
Table 63. Apotex Recent Development
Table 64. Glemark Generics Company Detail
Table 65. Glemark Generics Business Overview
Table 66. Glemark Generics Amyotrophic Lateral Sclerosis Drugs Product
Table 67. Glemark Generics Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2017-2022) & (US$ Million)
Table 68. Glemark Generics Recent Development
Table 69. Sun Pharma Company Detail
Table 70. Sun Pharma Business Overview
Table 71. Sun Pharma Amyotrophic Lateral Sclerosis Drugs Product
Table 72. Sun Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2017-2022) & (US$ Million)
Table 73. Sun Pharma Recent Development
Table 74. Covis Pharma Company Detail
Table 75. Covis Pharma Business Overview
Table 76. Covis Pharma Amyotrophic Lateral Sclerosis Drugs Product
Table 77. Covis Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2017-2022) & (US$ Million)
Table 78. Covis Pharma Recent Development
Table 79. Lunan Pharma Company Detail
Table 80. Lunan Pharma Business Overview
Table 81. Lunan Pharma Amyotrophic Lateral Sclerosis Drugs Product
Table 82. Lunan Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2017-2022) & (US$ Million)
Table 83. Lunan Pharma Recent Development
Table 84. CSPC Pharmaceutical Company Detail
Table 85. CSPC Pharmaceutical Business Overview
Table 86. CSPC Pharmaceutical Amyotrophic Lateral Sclerosis Drugs Product
Table 87. CSPC Pharmaceutical Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2017-2022) & (US$ Million)
Table 88. CSPC Pharmaceutical Recent Development
Table 89. Ascend Laboratories Company Detail
Table 90. Ascend Laboratories Business Overview
Table 91. Ascend Laboratories Amyotrophic Lateral Sclerosis Drugs Product
Table 92. Ascend Laboratories Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2017-2022) & (US$ Million)
Table 93. Ascend Laboratories Recent Development
Table 94. EISAI Company Detail
Table 95. EISAI Business Overview
Table 96. EISAI Amyotrophic Lateral Sclerosis DrugsProduct
Table 97. EISAI Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2017-2022) & (US$ Million)
Table 98. EISAI Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Type: 2021 VS 2028
Figure 2. Riluzole Features
Figure 3. Edaravone (Radicava) Features
Figure 4. CoQ10 Features
Figure 5. Butylphthalide Features
Figure 6. Others Features
Figure 7. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Application in 2021 & 2028
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Amyotrophic Lateral Sclerosis Drugs Report Years Considered
Figure 12. Global Amyotrophic Lateral Sclerosis Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Amyotrophic Lateral Sclerosis Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Region: 2021 VS 2028
Figure 15. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Players in 2021
Figure 16. Global Top Amyotrophic Lateral Sclerosis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amyotrophic Lateral Sclerosis Drugs as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Amyotrophic Lateral Sclerosis Drugs Revenue in 2021
Figure 18. North America Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. North America Amyotrophic Lateral Sclerosis Drugs Market Share by Country (2017-2028)
Figure 20. United States Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Amyotrophic Lateral Sclerosis Drugs Market Share by Country (2017-2028)
Figure 24. Germany Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Share by Region (2017-2028)
Figure 32. China Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Japan Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. South Korea Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Southeast Asia Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. India Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Australia Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Amyotrophic Lateral Sclerosis Drugs Market Share by Country (2017-2028)
Figure 40. Mexico Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Brazil Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Share by Country (2017-2028)
Figure 44. Turkey Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Saudi Arabia Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Sanofi Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2017-2022)
Figure 47. Mitsubishi Tanabe Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2017-2022)
Figure 48. Mylan Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2017-2022)
Figure 49. Apotex Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2017-2022)
Figure 50. Glemark Generics Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2017-2022)
Figure 51. Sun Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2017-2022)
Figure 52. Covis Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2017-2022)
Figure 53. Lunan Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2017-2022)
Figure 54. CSPC Pharmaceutical Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2017-2022)
Figure 55. Ascend Laboratories Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2017-2022)
Figure 56. EISAI Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2017-2022)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock
This site is protected by VikingCloud's Trusted Commerce program